|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||
| Cash | |||||||||||||||
| Accounts receivable, less allowance for credit losses | |||||||||||||||
| Amounts due from related parties | |||||||||||||||
| Other receivables and prepayments | |||||||||||||||
| Inventories | |||||||||||||||
| Total current assets | |||||||||||||||
| NON-CURRENT ASSETS | |||||||||||||||
| Plant and equipment, net | |||||||||||||||
| Deferred tax assets | |||||||||||||||
| Goodwill | |||||||||||||||
| Operating lease right-of-use assets, net | |||||||||||||||
| Total non-current assets | |||||||||||||||
| Total assets | |||||||||||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT) | |||||||||||||||
| CURRENT LIABILITIES | |||||||||||||||
| Accounts payable | |||||||||||||||
| Other payables and accrued liabilities | |||||||||||||||
| Deferred income | |||||||||||||||
| Amounts due to related parties | |||||||||||||||
| Operating lease liabilities, current | |||||||||||||||
| Loan from a related party | |||||||||||||||
| Current portion of finance lease liability | |||||||||||||||
| Short term bank loan from an affiliate | |||||||||||||||
| Total current liabilities | |||||||||||||||
| NON-CURRENT LIABILITIES | |||||||||||||||
| Deferred tax liabilities | |||||||||||||||
| Convertible loan from affiliates | |||||||||||||||
| Long term bank loan | |||||||||||||||
| Long term finance lease liability | |||||||||||||||
| Operating lease liabilities, non-current | |||||||||||||||
| Total non-current liabilities | |||||||||||||||
| Total liabilities | |||||||||||||||
| SHAREHOLDERS’ EQUITY (DEFICIT) | |||||||||||||||
| Common stock, 100,000,000 shares authorized, $0.00001 par value; 43,500,762 and 43,500,762 shares issued and outstanding, respectively | |||||||||||||||
| Additional paid-in capital | |||||||||||||||
| Statutory reserves | |||||||||||||||
| Accumulated deficit | |||||||||||||||
| Accumulated other comprehensive losses | |||||||||||||||
| Total shareholders’ equity (deficit) | |||||||||||||||
| Non-controlling interest | |||||||||||||||
| Shareholders’ equity (deficit) | |||||||||||||||
| Total liabilities and shareholders’ equity (deficit) | |||||||||||||||
Loading...
